Systematic Review and Meta-analysis: The Effects of Prophylactic Proton Pump Inhibitor Treatment in Patients With Coronary Heart Disease Receiving Dual Antiplatelet Therapy
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Pharmacology
Reference72 articles.
1. Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines;Bittl;J Am Coll Cardiol.,2016
2. ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison;Capodanno;J Am Coll Cardiol.,2018
3. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events;Fortuna;Eur Heart J Cardiovasc Pharmacother.,2016
4. Effect of omeprazole on the bioavailability of unmodified and phospholipid-complexed aspirin in rats;Giraud;Aliment Pharmacol Ther.,1997
5. Aspirin and proton-pump inhibitors: interpreting the interplay;Vaduganathan;Eur Heart J Cardiovasc Pharmacother.,2016
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?;Expert Opinion on Drug Metabolism & Toxicology;2024-07-15
2. Role of Proton Pump Inhibitors in Cardiac Patients: Guideline Recommendations Versus Practical Approach;Indian Journal of Clinical Cardiology;2024-06-08
3. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view;World Journal of Cardiology;2023-08-26
4. Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects;Pharmaceutics;2023-02-07
5. Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis;Frontiers in Pharmacology;2023-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3